Serum Institute says they've produced 40 million doses of the AstraZeneca COVID-19 vaccine

Serum said it has enrolled 1,600 participants in India for late-stage trials of AstraZeneca's candidate, and also plans to seek regulatory approval to run late-stage trials for the Novavax vaccine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2UjQk66
via IFTTT